Extended Data Fig. 8: Kinetics of binding to the RBD of wild-type and spike(E484K) SARS-CoV-2 for 46 RBD-specific monoclonal antibodies.
From: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
a, b, Binding to the RBD of wild-type (black) and spike(E484K) (red) SARS-CoV-2 by 27 RBM-targeting (a) and 19 non-RBM-targeting (b) monoclonal antibodies. An antibody of irrelevant specificity was included as a negative control.